Merck defends blockbuster Januvia franchise from patent challenge Merck & Co has been fighting to defend its blockbuster type 2 diabetes therapy Januvia from generic competition for years, and a new judgment looks set to protect its third biggest-selling drug for another few years
Severe nausea (inability to keep food or water down for more than 12 hours) may require dose reduction, extended titration at the current level, or anti-nausea medication like ondansetron
Your dose may increase as treatment progresses, but your price won't: PlexusDx maintains flat monthly pricing across all commitment tiers, eliminating surprise cost jumps that often force patients to abandon therapy prematurely
The mention of ongoing collaboration with major pharmaceutical manufacturers may raise concerns about the company's reliance on external partners for critical aspects of its service offerings
Metformin is an insulin sensitizer that helps the body use existing insulin more effectively, while Ozempic is a hormone mimic that promotes new insulin secretion
So one of the main reasons that Topamax may not be working for you is that you are targeting the wrong problem